About Cyclarity Therapeutics
Cyclarity Therapeutics is a private company based in Novato, California. It has reported $15,257,310 raised in three offerings on Form D since November 2019. Its chief executive is Matthew O'Connor.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Dec 16, 2024 | Dec 30, 2024 | $10,288,140of $12.8M target | 19 | $541K | EquityRule 506(b) | Form D ↗ |
| Aug 24, 2021 | Sep 7, 2021 | $3,519,169of $9.9M target | 10 | $351K | EquityRule 506(b) | Form D ↗ |
| Nov 12, 2019 | Nov 25, 2019 | $1,450,001of $3.9M target | 9 | $161K | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $15,257,310 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Cyclarity Therapeutics's Form D filed Dec 30, 2024.
MC
Matthew O'Connor
Co-Chief Executive Officer and director
MK
Michael Kope
Executive officer and director
Earlier filings also listed Frank Schueler (director, last listed Sep 2021).